Others are also emerging on the arterial hypertension front with the development of aldosterone synthase inhibition and zilebesiran, the first small interfering RNA (siRNA) designed to reduce angiotensinogen mRNA in the hepatocytes [12,13]. The gene discussed is CYP11B2; the disease is Hypertension.